Physician profile
Dong Park
NPI 1174794788
$22,166.35
in general payments reported to CMS, 2019-2025
73 companies · $3,130 in 2025
The $3,130 reported for 2025 was more than what 79% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,441 · 2020: $3,082 · 2021: $3,773 · 2022: $3,429 · 2023: $3,019 · 2024: $3,293 · 2025: $3,130.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,441.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,441.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $2,499.18 | 2019-2025 | Austedo Xr, Austedo Xr, Austedo |
| Abbvie INC. | $1,601.25 | 2020-2025 | |
| Novartis Pharmaceuticals Corporation | $1,222.82 | 2019-2025 | |
| Lundbeck LLC | $1,048.31 | 2019-2025 | Vyepti, Rexulti |
| Lilly USA, LLC | $922.97 | 2019-2025 | Amyvid, Emgality, Kisunla |
| Ucb, INC. | $858.53 | 2019-2025 | Rystiggo, Briviact, Zilbrysq |
| Emd Serono, INC. | $833.48 | 2019-2025 | Mavenclad |
| Amneal Pharmaceuticals LLC | $777.64 | 2019-2025 | Crexont, Rytary, Ongentys 50mg Capsules 30 |
| Biogen, INC. | $770.72 | 2019-2023 | Tysabri, Vumerity, Skyclarys |
| Sunovion Pharmaceuticals INC. | $708.77 | 2019-2022 | |
| Eisai INC. | $625.34 | 2019-2025 | |
| Pfizer INC. | $576.53 | 2019-2025 | |
| Amgen INC. | $575.55 | 2019-2025 | Aimovig, Repatha, Uplizna |
| Banner Life Sciences, LLC | $547.38 | 2021-2024 | |
| Genzyme Corporation | $531.55 | 2019-2025 |
Show all 73 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dong Park listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.